SCHEMBL17381587

SCHEMBL17381587

COc1cc2c(cc1-c1cncc(C(N)=O)c1)-c1c(c(C(=O)N3CCOCC3(C)C)nn1-c1cc(F)cc(F)c1)CO2

nearest known ligand 0.32

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.32
▸ PIK3CD O00329 4/20 0.31
▸ PIK3R2 O00459 4/20 0.31
▸ PIK3CA P42336 4/20 0.31
▸ PIK3CB P42338 4/20 0.31
▸ PIK3CG P48736 4/20 0.31
▸ PIK3R5 Q8WYR1 4/20 0.31
▸ PIK3R3 Q92569 4/20 0.31
▸ IKBKB O14920 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20731124 0.96 GRM5 (0.32) GRM5
SCHEMBL30681691 0.96 GRM5 (0.32) GRM5
SCHEMBL17382077 0.94 — —
SCHEMBL17382050 0.93 GRM5 (0.33) GRM5PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL30681670 0.93 GRM5 (0.33) GRM5PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL17381644 0.93 PIK3CD (0.35) PIK3CDPIK3R2PIK3CAPIK3CBPIK3CG
SCHEMBL30886053 0.92 GRM5 (0.33) GRM5PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL17382140 0.90 PIK3CD (0.33) GRM5PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL17382114 0.90 PIK3CD (0.31) GRM5PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL27123503 0.89 IKBKB (0.37) GRM5PIK3CDPIK3R2PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3157929-B1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF ARES TRADING SA (CH) 2023-12-13 — — EP disclosed
US-20220402929-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF TOCOPHERX INC (US) 2022-12-22 — — US disclosed
US-10941152-B2 Pyrazole compounds as modulators of FSHR and uses thereof ARES TRADING S.A. (CH) 2021-03-09 — — US disclosed
US-20190135823-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF TOCOPHERX, INC. 2019-05-09 — — US disclosed
US-10208055-B2 Pyrazole compounds as modulators of FSHR and uses thereof TOCOPHERX, INC. (US) 2019-02-19 — — US disclosed
US-10208055-B2 Pyrazole compounds as modulators of FSHR and uses thereof TOCOPHERX, INC. (US) 2019-02-19 — — US disclosed
US-20170253605-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF TOCOPHERX, INC. (US) 2017-09-07 — — US disclosed
US-20170253605-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF TOCOPHERX, INC. (US) 2017-09-07 — — US disclosed
WO-2015196759-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF TOCOPHERX, INC. (US) 2015-12-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208055-B2 Pyrazole compounds as modulators of FSHR and uses thereof FSHR, GNRHR, LHCGR GRM5 299/4885PIK3CD 799/4885PIK3R2 353/4885
US-20170253605-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF FSHR, GNRHR, LHCGR GRM5 299/4885PIK3CD 799/4885PIK3R2 353/4885
US-20190135823-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF FSHR, GNRHR, LHCGR GRM5 301/4885PIK3CD 927/4885PIK3R2 274/4885
US-20220402929-A1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF FSHR, GNRHR, LHCGR GRM5 301/4885PIK3CD 927/4885PIK3R2 274/4885
US-10941152-B2 Pyrazole compounds as modulators of FSHR and uses thereof FSHR, GNRHR, LHCGR GRM5 301/4885PIK3CD 927/4885PIK3R2 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback